EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Study on Evaluation of Serum Cardiac Marker and Ferritin Levels in COVID 19 Patients

Manjula Halevooru Siddarajaiah, P. Vijayalakshmi, Sharan Prasad Chandrashekarpura Shivapra, Vishesh Siddesh

Medical Research Archives · 29.06.2025 · 13 (6)

DOI: 10.18103/mra.v13i6.6611 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Medical Research Archives, online erschienen am 29.06.2025. Verfasst von Manjula Halevooru Siddarajaiah und 3 weiteren Autor:innen. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

COVID 19 pandemic is a systemic inflammatory condition caused by novel severe acute respiratory syndrome (SARS)CoV 2 virus infecting humans. The role of pro inflammatory cytokines such as interleukin (IL) 6, IL 12, IL 8 and tumour necrosis factor alpha causing dysfunctional immune response during the disease progression leads to acute respiratory distress syndrome and systemic organ failure. Ferritin is linked with COVID as a feature of respiratory oxidative stress (ROS) generation and secondary tissue damage. On the other side NTproBNP (N terminal pro brain natriuretic peptide) a heart failure marker also carries prognostic value in noncardiac conditions such as lung disease like in chronic obstructive pulmonary disease. However, its role in patients with COVID-19 and its prognostic value is still not well-established. Also, the relationship of ferritin an inflammatory marker with NTproBNP released in widespread alveolar damage or multi‑organ failure, and eventually death is not available widely.

Aim

The aim of the study is to evaluate the possible association between the N-terminal pro-brain type natriuretic peptide (NT-proBNP) levels and ferritin as a prognostic or diagnostic marker in COVID19 cases. Methods and Material: This is a institutional record based cross sectional study, collected from records of patients admitted over a period of 4 months (July 2020-October 2020) at Jayadeva Institute of Cardiac sciences, Bengaluru, Karnataka, India. A total of 100 covid-19 patients were selected as per convenient sampling with CI-95% from the MRD case chart. Descriptive statistical analysis of data was done. Categorical variables such as age and gender were presented in (n)%. Continuous variables were expressed as mean±SD. ANOVA test was used to compare the parameters between quartiles (Q1- Q4) of Ferritin, p

Zitieren

APA

Siddarajaiah, M. H., Vijayalakshmi, P., Shivapra, S. P. C., & Siddesh, V. (2025). Study on Evaluation of Serum Cardiac Marker and Ferritin Levels in COVID 19 Patients. Medical Research Archives, 13(6). https://doi.org/10.18103/mra.v13i6.6611

Vancouver

Siddarajaiah MH, Vijayalakshmi P, Shivapra SPC, Siddesh V. Study on Evaluation of Serum Cardiac Marker and Ferritin Levels in COVID 19 Patients. Medical Research Archives. 2025;13(6). doi:10.18103/mra.v13i6.6611

BibTeX
@article{Siddarajaiah2025,
  author = {Siddarajaiah, Manjula Halevooru and Vijayalakshmi, P. and Shivapra, Sharan Prasad Chandrashekarpura and Siddesh, Vishesh},
  title = {Study on Evaluation of Serum Cardiac Marker and Ferritin Levels in COVID 19 Patients},
  journal = {Medical Research Archives},
  year = {2025},
  volume = {13},
  number = {6},
  doi = {10.18103/mra.v13i6.6611}
}
Kostenlos starten →